Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Jazz enters oncology space through $650mm purchase of EUSA Pharma

Executive Summary

Jazz Pharmaceuticals PLC (women’s health and neurology) will pay $650mm up front, plus up to $50mm in sales-based earn-outs, to acquire EUSA Pharma Inc., a private specialty pharmaceuticals company that develops and sells therapies for cancer and cancer supportive care.
Deal Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Medical Devices
    • Implantable Devices
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Full Acquisition
    • Payment Includes Cash
    • Includes Contract
    • Acquisition of Private Biotech

Related Companies

Advertisement
UsernamePublicRestriction

Register